Updated:
Swan Ventures
Dr. Jonathan Parmer’s boutique fund-of-funds manager, founded in 2000 to give Silicon Valley physicians venture access, now raising Fund III from San...
Swan Ventures
Swan Ventures is a boutique fund-of-funds manager founded in 2000 by Dr. Jonathan Parmer, a retired Ob/Gyn and Princeton and NYU School of Medicine alumnus who completed his residency at Stanford. The firm’s original vehicle pooled capital from Silicon Valley physicians seeking diversified exposure to venture capital, with a particular concentration on healthcare and biotechnology. After two funds, the limited partner base has grown to include high-net-worth individuals and institutional investors, and the portfolio has tilted further beyond pure healthcare. Swan commits capital to venture capital funds rather than making direct company investments. Early funds focused on healthcare and biotech venture firms, while later allocations deliberately broadened the industry mix. Geographic reach is rooted in the US innovation economy, with manager relationships concentrated in Silicon Valley during the firm’s early years and increasingly national in scope as the LP base diversified. Day-to-day management is led by two Managing Partners: founder Jonathan Parmer and his daughter, Kathleen Parmer. Kate Parmer brought two decades of financial and operational experience from Franklin Templeton, State Street Global Advisors, S&P Global Ratings, and LPL Financial before joining the firm full-time. In 2020, she took a senior operations role at LPL Financial overseeing over 3 million advisory accounts and has since transitioned exclusively to Swan Ventures. The firm is preparing to launch Swan Ventures III, which will be based in San Diego, marking a shift from the original Montana headquarters. Swan Ventures couples a generalist fund-of-funds structure with a medical-founder lineage, giving it an unusual dual identity: a multi-generational family-managed investment vehicle that originated inside the physician community. Its ongoing philanthropic commitment — originally tied to women’s health and the medical-device work of its founder’s former company, Viveve Corporation — reinforces the healthcare-origin strand even as the portfolio evolves.
General information
Firm type
Private Equity
Year founded
2000
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bigfork
Corporate office
Bigfork, MT, United States
Additional offices
San Diego, CA, United States
Principals
Jonathan Parmer
Managing Partner
Kathleen Parmer
Managing Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Swan Ventures?
Jonathan Parmer, the founder, and his daughter Kathleen Parmer are both Managing Partners and jointly oversee investment decisions. Jon Parmer built the fund-of-funds portfolio from the firm’s inception in 2000; Kate Parmer, who moved into the role full-time after a career spanning S&P Global Ratings, State Street Global Advisors, and LPL Financial, now co-manages manager selection and portfolio construction.
Does Swan Ventures invest directly in companies or only through funds?
Swan Ventures operates exclusively as a fund-of-funds, committing to venture capital managers rather than making direct company investments. The firm’s stated purpose since inception has been to provide limited partners with diversified exposure to venture capital via carefully selected external fund managers.
What is the wealth origin behind Swan Ventures?
The founding capital originated with Dr. Jonathan Parmer’s private Ob/Gyn practice in Palo Alto and his role as founder and initial CEO of Viveve Corporation, a women’s health medical-device company. Parmer assigned multiple US and international patents to Viveve and later sold the intellectual property to an international healthcare company.
How is Swan Ventures related to Viveve Corporation?
Viveve Corporation (originally TivaMed) was founded in 2005 by Jonathan Parmer, who served as its initial CEO and assigned several patents to the company. Parmer left Viveve in 2009. The company no longer exists, but its intellectual property and Parmer’s patents were purchased by an international healthcare company, for which Parmer now consults.
What is Swan Ventures III and where will it operate?
Swan Ventures III is the firm’s third fund-of-funds vehicle, currently in formation. It will be based in San Diego, California, where Managing Partner Jonathan Parmer relocated after leaving Silicon Valley. The move represents a geographic shift from the firm’s historical operations tied to Bigfork, Montana and its original Silicon Valley physician network.
What is the philanthropic component of Swan Ventures’ strategy?
Swan Ventures integrates philanthropy into its investment approach, continuing a focus on healthcare-related giving that originated with Fund I’s physician LP base. The firm states it remains dedicated to healthcare philanthropy, a commitment rooted in the founder’s medical career and his work in women’s health and medical devices.
How should institutional allocators think about Swan Ventures’ size and scale?
Swan Ventures is a compact, family-run fund-of-funds manager that has raised two prior vehicles and is launching a third. The firm does not publicly disclose assets under management or fund sizes, and the investment team consists solely of the two Managing Partners, making it a small, concentrated decision-making unit by institutional standards.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: